ArticleBMC plant biology2026
Physiological and transcriptomic analyses for assessing the effects of uniconazole on female ear development in maize (Zea Mays L.).
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe maize female ear is a key reproductive organ whose morphology directly determines yield. Uniconazole, a gibberellin (GA) biosynthesis inhibitor, is used to regulate ear development and improve yield. However, its mode of action on ear morphogenesis remains incompletely defined.
resultsWe foliar-applied uniconazole (25 mg L–1) at the 12-leaf stage and evaluated ear development using morphology, physiology, and transcriptomics. Uniconazole shortened ear length while significantly increasing ear diameter, cob cross-sectional area, and cob cell-wall thickness. The changes of female ear morphology were accompanied by alterations in hormone (IAA, GA, ABA, ZR) levels and carbohydrate (cellulose, hemicellulose, lignin) profiles. Transcriptome analysis revealed a widespread transcriptional reprogramming. This reprogramming was characterized by the down-regulation of putative growth-restricting receptor kinases (e.g., LRR, PERK) and the concerted up-regulation of master transcriptional regulators (NAC, MYB) of secondary cell-wall biosynthesis. In hormone signaling, the down-regulation of auxin-responsive genes and the up-regulation of DELLA repressors indicated the suppression of both IAA and GA signaling pathways. Concurrently, the phenylpropanoid biosynthesis pathway was strongly activated, aligning with enhanced lignin deposition.
conclusionsUniconazole reshapes maize female ears into a shorter length and thicker diameter morphology. This is achieved through a coordinated molecular mechanism involving hormone rebalancing, repression of the GA-DELLA signaling pathway, and activation of the NAC/MYB-mediated secondary cell wall biosynthesis pathway. Our findings provide a mechanistic basis for the targeted use of uniconazole in maize cultivation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.